These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 934347)

  • 1. Morocromen, a new 2-oco-benzopyranylcarboxamide with strong coronary activity.
    Becker KH; Boltze KH; Dell HD; Jacobi H; Seidel PR
    Naturwissenschaften; 1976 Mar; 63(3):148-9. PubMed ID: 934347
    [No Abstract]   [Full Text] [Related]  

  • 2. New coronary active benzopyranone derivatives.
    Jacobi H; Boltze KH; Seidel PR; Schwarz H
    Naturwissenschaften; 1977 Apr; 64(4):225. PubMed ID: 865640
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacological profile of razinodil as a possible new drug for ischemic myocardial diseases.
    Hashimoto K; Nakagawa Y; Tsukada T; Hashimoto T; Satoh H; Chin WP; Katano Y; Imai S
    Arzneimittelforschung; 1981; 31(5):781-5. PubMed ID: 7196735
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of various coronary vasodilators on myocardial oxygen consumption.
    Oguro K; Kubota K; Kimura T; Hashimoto K
    Jpn J Pharmacol; 1973 Aug; 23(4):459-66. PubMed ID: 4202125
    [No Abstract]   [Full Text] [Related]  

  • 5. Nebivolol in patients with coronary slow flow: the right drug for the right case?
    Fragasso G
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):296-7. PubMed ID: 19666431
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
    Hirata Y; Aisaka K
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of molsidomine on coronary collateral blood flow in acute myocardial ischemia.
    Gross GJ; Gharaibeh M
    Eur J Pharmacol; 1980 Oct; 67(1):111-4. PubMed ID: 6893436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the KATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs.
    Yao Z; Gross GJ
    Circulation; 1994 Apr; 89(4):1769-75. PubMed ID: 8149542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique effect of nebivolol on coronary hemodynamics: it's all a matter of flow.
    Lev EI; Battler A
    Cardiovasc Drugs Ther; 2007 Apr; 21(2):75-6. PubMed ID: 17417696
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in local myocardial blood circulation following oral administration of a Crataegus extract in non-narcotized dogs].
    Mävers WH; Hensel H
    Arzneimittelforschung; 1974 May; 24(5):783-5. PubMed ID: 4408035
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardiovascular pharmacology of SKP-450, a new potassium channel activator, and its major metabolites SKP-818 and SKP-310.
    Shin HS; Seo HW; Yoo SE; Lee BH
    Pharmacology; 1998 Mar; 56(3):111-24. PubMed ID: 9532610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
    Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential action of nitrate derivatives and arterial vasodilators on coronary circulation. An experimental approach and therapeutic consequences].
    Drieu la Rochelle C; Roupie E; Richard V; Giudicelli JF; Berdeaux A
    Arch Mal Coeur Vaiss; 1992 Apr; 85 Spec No 1():67-71. PubMed ID: 1530432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of YM099, a novel K+ channel opener, in anesthetized and conscious dogs.
    Uchida W; Hirano Y; Taguchi T; Masuda N; Shirai Y; Satoh N; Takenaka T
    Eur J Pharmacol; 1994 Nov; 264(3):285-93. PubMed ID: 7698167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of coronary-active compounds and anti-inflammatory drugs on the coronary vascular system (author's transl)].
    Jacobi H; Jentzsch KR; Lüdtke W; Schwarz H
    Arzneimittelforschung; 1981; 31(10):1704-10. PubMed ID: 7198446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of vasodilator effects of the potassium channel openers NIP-121 and levcromakalim in dogs and rats.
    Yamashita T; Masuda Y; Kawamura N; Fujikura N; Tanaka S
    Jpn J Pharmacol; 1995 Jun; 68(2):145-52. PubMed ID: 7563971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
    Giudicelli JF; la Rochelle CD; Berdeaux A
    J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity of BMS-180448 on myocardial versus brain blood flow in dogs and ferrets.
    Weselcouch EO; Gomoll AW
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):61-8. PubMed ID: 9268222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intravenously and orally administered cinpropazide on the coronary circulation in unanesthetized and unrestrained dogs.
    Nonaka K; Ueno A
    Arzneimittelforschung; 1985; 35(10):1499-502. PubMed ID: 4074404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and selective coronary vasodilatory activity of 3,4-dihydro-2,2-bis(methoxymethyl)-2H-1-benzopyran-3-ol derivatives: novel potassium channel openers.
    Cho H; Katoh S; Sayama S; Murakami K; Nakanishi H; Kajimoto Y; Ueno H; Kawasaki H; Aisaka K; Uchida I
    J Med Chem; 1996 Sep; 39(19):3797-805. PubMed ID: 8809167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.